Adaptive Biotechnologies Corpor

Historical 13F Holders

Symbol
ADPT
CUSIP
00650F109
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 229 153 M $1.13 B
2024 Q4 212 143 M $858 M
2024 Q3 194 144 M $737 M
2024 Q2 183 150 M $543 M
2024 Q1 198 144 M $462 M
2023 Q4 210 146 M $714 M
2023 Q3 199 141 M $770 M
2023 Q2 219 137 M $921 M
2023 Q1 237 134 M $1.18 B
2022 Q4 236 135 M $1.03 B
2022 Q3 237 131 M $932 M
2022 Q2 221 134 M $1.08 B
2022 Q1 233 126 M $1.74 B
2021 Q4 225 124 M $3.48 B
2021 Q3 228 118 M $4.01 B
2021 Q2 243 118 M $4.81 B
2021 Q1 263 114 M $4.60 B
2020 Q4 269 114 M $6.77 B
2020 Q3 220 111 M $5.41 B
2020 Q2 213 101 M $4.89 B
2020 Q1 156 97.1 M $2.70 B
2019 Q4 141 86.5 M $2.59 B
2019 Q3 126 82.0 M $2.52 B
2019 Q2 113 78.2 M $3.74 B
2019 Q1 1 104 k $4.25 M
2016 Q3 1 235 $10.1 k